NGVTNGVTBasic Materials · Specialty Chemicals

NGVT Stock Forecast: Ingevity Corp. Price Predictions for 2026-2027

Last close, 11 Sept 2026
$69
+3.40% on the day

The 3 Wall Street analysts covering Ingevity Corp. hold a median 12-month price target of $90 — +29.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 99 of 100 as at 11 Sept 2026 — among the strongest tenth. Here, the model and the Street point the same way.

Market cap
$2.4B
Ticker Nerd rank
99 / 100
Median analyst target
$90
Analysts covering
3
Revenue$314.1M−14.0% y/y
Operating income$93.9M
Net income$35.3M
Free cash flow−$24.1M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−0.6%
1M
−10.8%
YTD
+17.3%
1Y
+18.1%
From 52W high
−10.9%
From 52W low
+50.2%
$46
$78
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

NGVT stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Ingevity Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 11 Sept 2026
99 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Issuance
99
Accruals
98
Revisions
93
Quality
92
Value
84
Momentum
80
Volatility
54
Growth
37
Size
33

Issuance (99): The share count has been shrinking and the company is not leaning on new borrowing.

Growth (37): Sales and profits are flat, shrinking, or growing more slowly than they were.

Size (33): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

NGVT stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on NGVT, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$40$50$60$70$80$90Oct 25Jan 26Apr 26Jul 26NGVTHigh $92Median $90Low $85

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says3 analysts
3 Buy0 Hold0 Sell
Low $85Median $90High $92

The green dot is the last close — the median target sits +29.7% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
27 Feb 2026Wells FargoMaintainsEqual-Weight$65$75
29 Jan 2026Wells FargoMaintainsEqual-Weight
19 Dec 2025Wells FargoMaintainsEqual-Weight
10 Dec 2025BMO CapitalMaintainsOutperform
12 Nov 2025Wells FargoMaintainsEqual-Weight
5 Sept 2025BMO CapitalMaintainsOutperform
7 Aug 2025BMO CapitalMaintainsOutperform
14 July 2025Wells FargoMaintainsEqual-Weight
7 May 2025Wells FargoMaintainsEqual-Weight
9 Apr 2025Wells FargoMaintainsEqual-Weight
26 Feb 2025BMO CapitalUpgradeOutperform
20 Feb 2025BMO CapitalMaintainsMarket Perform
31 Oct 2024BMO CapitalMaintainsMarket Perform
30 Sept 2024BMO CapitalMaintainsMarket Perform
5 Aug 2024BMO CapitalMaintainsMarket Perform
5 Aug 2024Wells FargoMaintainsEqual-Weight
1 Aug 2024OppenheimerMaintainsOutperform
11 July 2024Wells FargoMaintainsEqual-Weight
8 May 2024BMO CapitalMaintainsMarket Perform
7 May 2024Loop CapitalMaintainsHold

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. NGVT appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

NGVT vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 11 Sept 2026, Ingevity Corp. returned +18.1% against +17.5% for the S&P 500, dividends included.

NGVT vs S&P 500, last 12 monthsTotal return, rebased to 100
8090100110120130Oct 25Jan 26Apr 26Jul 26NGVTS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

NGVT analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+9.2%
Analysts raising
2
Analysts cutting
0
Fundamentals

Ingevity Corp. (NGVT) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
97.8×

Cheaper than 7% of US stocks

Price / sales
2.1×

Cheaper than 53% of US stocks

Price / book
51.0×

Cheaper than 2% of US stocks

EV / EBITDA
9.5×

Cheaper than 41% of US stocks

Growth & margins
Revenue growth (YoY)
−5.2%

Higher than 20% of US stocks

Earnings growth (YoY)
−14.0%

Higher than 24% of US stocks

Gross margin
44.3%

Higher than 55% of US stocks

Operating margin
29.9%

Higher than 87% of US stocks

Net margin
4.7%

Higher than 59% of US stocks

Returns & dividend
Return on equity
30.1%

Higher than 88% of US stocks

Return on assets
10.4%

Higher than 92% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Ingevity Corp. (NGVT) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Ingevity Corp. has a market value of $2.4B and an enterprise value of $3.5B.

  • Revenue in the twelve months to 30 June 2026: $1.2B. The latest quarter shrank 5.2% year on year.

  • Net income over the same four quarters: $54.0M, a 4.7% net margin.

  • Diluted earnings per share, trailing twelve months: $1.47.

  • Free cash flow in the twelve months to 30 June 2026: $154.9M, after $56.1M of capital spending.

  • Ingevity Corp. spent $143.1M on share buybacks in the twelve months to 30 June 2026.

  • Shares outstanding: 34.5M.

  • Trailing P/E: 97.8×; forward P/E: 11.5× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Ingevity Corp. employs 1,400 people $829K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 13 Sept 2026

Data provided by Twelve Data

Peers

NGVT vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSpecialty Chemicals
CompanyMarket capTKN rank
NGVTIngevity Corp.$2.4B
99
HWKNHawkins, Inc.$2.6B
70
WDFCWD-40 Co.$2.6B
71
KWRQuaker Houghton$2.7B
93
IOSPInnospec, Inc.$2.3B
89
CCThe Chemours Co.$2.3B
61
FULH.B. Fuller Co.$2.8B
90

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Ingevity Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest NGVT news & analysis

Ingevity Shares Rise 19.2% YTD: Can the Stock Sustain the Rally?

Zacks Investment Research · 8 Sept 2026positive

Ingevity Corp. shares have risen 19.2% year-to-date, according to Zacks Investment Research. The rally is attributed to portfolio optimization, stronger demand for hybrids, pricing gains, and higher margins, which are fueling earnings growth.

Why it matters — For NGVT watchers, the continued rise highlights the company's operational improvements and margin expansion as key drivers sustaining its share-price performance.

Ingevity CEO Dave Li and CFO Phil Platt to speak at 2026 Jefferies Global Industrials Conference

Business Wire · 3 Sept 2026neutral

Ingevity announced that CEO Dave Li and CFO Phil Platt will participate in a fireside chat at the 2026 Jefferies Global Industrials Conference, as detailed in a Business Wire release from North Charleston, S.C.

Why it matters — The company's leadership will be publicly addressing investors and analysts at a major industry conference, offering a chance for updates and visibility into Ingevity's operations.

Ingevity (NGVT) Down 0.6% Since Last Earnings Report: Can It Rebound?

Zacks Investment Research · 28 Aug 2026negative

Ingevity (NGVT) reported earnings 30 days ago, and its stock has declined 0.6% since then. The article questions whether the stock can rebound following the earnings report.

Why it matters — NGVT watchers care because the stock's post-earnings performance and the question of a rebound signal current market sentiment around the company's recent results.

Ingevity: Portfolio Simplification Reveals A High-Margin Regulatory Compounder

Seeking Alpha · 28 Aug 2026positive

Ingevity is focusing on its high-margin Performance Materials and Pavement Technologies segments after divesting lower-quality, volatile businesses. Q2 2026 results showed adjusted EBITDA up 14% to $115M with margins at 36.6% and EPS rising to $1.74, supported by hybrid vehicle adoption, infrastructure spending, and PFAS filtration growth optionality.

Why it matters — NGVT watchers would note the company's portfolio simplification and margin expansion signal a shift toward a more stable, higher-quality regulatory compounder with resilient demand drivers.

Why You Should Add Ingevity Stock to Your Portfolio Now

Zacks Investment Research · 26 Aug 2026positive

Zacks coverage highlights Ingevity's raised 2026 outlook, portfolio transformation, and new growth platforms as supporting its momentum and focus on higher-return investments. The article frames these elements as reasons to add NGVT stock to a portfolio.

Why it matters — NGVT watchers would care because the item signals an improved company outlook and strategic shifts toward new growth areas that could shape its longer-term direction.

FAQ

Frequently asked questions about NGVT stock

What is the NGVT stock price forecast for 2026-2027?

The 3 Wall Street analysts covering Ingevity Corp. have a median 12-month price target of $90, with estimates ranging from $85 to $92. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is NGVT stock a buy right now?

Of the 3 analysts covering Ingevity Corp., 3 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Ingevity Corp. 99 out of 100 across roughly 4,600 US stocks as at 11 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank NGVT?

As at 11 Sept 2026, Ingevity Corp. ranks 99 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (99 of 100).

Will NGVT stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +29.7% from the last close, and Ticker Nerd's factor model ranks Ingevity Corp. 99 out of 100 as at 11 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the NGVT stock forecast for 2030?

No analyst covering Ingevity Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NGVT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $85 to $92 over the next 12 months.

How has NGVT stock performed over the past year?

Ingevity Corp. returned +18.1% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Ingevity Corp. do?

Ingevity Corporation is a specialty materials and chemical manufacturing company that develops and sells activated carbon products, specialty chemicals, and engineered polymers. Its products are used in emissions control, industrial purification, pavement technologies, adhesives, coatings, resins, elastomers, lubricants, agrochemicals, and other performance applications.

What is the latest news on NGVT?

The most recent item we track (Zacks Investment Research, 8 Sept 2026): "Ingevity Shares Rise 19.2% YTD: Can the Stock Sustain the Rally?". Ingevity Corp. shares have risen 19.2% year-to-date, according to Zacks Investment Research. The rally is attributed to portfolio optimization, stronger demand for hybrids, pricing gains, and higher margins, which are fueling earnings growth.

Company

About Ingevity Corp.

Ingevity Corporation is a specialty materials and chemical manufacturing company that develops and sells activated carbon products, specialty chemicals, and engineered polymers. Its products are used in emissions control, industrial purification, pavement technologies, adhesives, coatings, resins, elastomers, lubricants, agrochemicals, and other performance applications. The company serves customers across a broad range of industries, including automotive, infrastructure, water and process treatment, and industrial manufacturing. Ingevity organizes its business around Performance Materials, Performance Chemicals, and Advanced Polymer Technologies, with solutions designed to help customers improve product performance, durability, and process efficiency. Headquartered in North Charleston, South Carolina, Ingevity operates with a global commercial and manufacturing footprint spanning North America, Europe, Asia Pacific, and other international markets.

CEO Mr. David H. Li · 1,400 employees · United States · https://www.ingevity.com